Researchers at UMass Amherst have combined high-throughput laboratory screening with an AI neural network to identify ...
Researchers have identified 15-PGDH enzyme inhibition as a neuroprotective strategy in Parkinson's disease, with repurposable ...
Cambridge-based cell programming company bit.bio has introduced two new media kits for its iPSC-derived ioGlutamatergic ...
A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...
A peptide vaccine targeting PCSK9 has demonstrated sustained antibody responses and reductions in LDL cholesterol and atherosclerotic plaque formation in animal models, offering a potential long-term ...
Researchers at Mount Sinai have developed the first fully human monoclonal antibody cocktail to provide complete protection against Nipah and Hendra viruses in preclinical models, offering a potential ...
Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...
A biomechanical well plate inspired by the pressure-sensing lateral line of fish can wirelessly monitor the pulse of multiple ...
Dr Veronica Fowler is Head of BioPharma, Product Management at Oxford Nanopore Technologies. She holds a PhD in virology from the Royal Veterinary College and has spent more than 25 years working ...
One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...
Non-animal methods are already used throughout early drug discovery, yet animal testing continues to dominate regulatory safety assessment. Recent initiatives suggest change is coming, but significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results